# ERLOTINIB HYDROCHLORIDE
> **ANDA214719** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2021-07-08
## Drug
- **FDA Application Number:** ANDA214719
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERLOTINIB HYDROCHLORIDE
- **Generic name:** ERLOTINIB HYDROCHLORIDE
- **Active ingredients:** ERLOTINIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2021-07-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214719)
---
*AI Analytics · CC0 1.0*